Your browser doesn't support javascript.
loading
Initial Testing (Stage 1) of MK-8242-A Novel MDM2 Inhibitor-by the Pediatric Preclinical Testing Program.
Kang, Min H; Reynolds, C Patrick; Kolb, E Anders; Gorlick, Richard; Carol, Hernan; Lock, Richard; Keir, Stephen T; Maris, John M; Wu, Jianwrong; Lyalin, Dmitry; Kurmasheva, Raushan T; Houghton, Peter J; Smith, Malcolm A.
Afiliação
  • Kang MH; Cancer Center, Texas Tech University Health Sciences Center, Lubbock, Texas.
  • Reynolds CP; Cancer Center, Texas Tech University Health Sciences Center, Lubbock, Texas.
  • Kolb EA; A.I. duPont Hospital for Children, Wilmington, Delaware.
  • Gorlick R; The Children's Hospital at Montefiore, Bronx, New York.
  • Carol H; Children's Cancer Institute Australia for Medical Research, Randwick, NSW, Australia.
  • Lock R; Children's Cancer Institute Australia for Medical Research, Randwick, NSW, Australia.
  • Keir ST; Duke University Medical Center, Durham, North Carolina.
  • Maris JM; Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine and Abramson Family Cancer Research Institute, Philadelphia, Pennsylvania.
  • Wu J; St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Lyalin D; Nationwide Children's Hospital, Columbus, Ohio.
  • Kurmasheva RT; Nationwide Children's Hospital, Columbus, Ohio.
  • Houghton PJ; Nationwide Children's Hospital, Columbus, Ohio.
  • Smith MA; Cancer Therapy Evaluation Program, NCI, Bethesda, Maryland.
Pediatr Blood Cancer ; 63(10): 1744-52, 2016 10.
Article em En | MEDLINE | ID: mdl-27238606

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Citarabina / Proteínas Proto-Oncogênicas c-mdm2 / Antineoplásicos Idioma: En Revista: Pediatr Blood Cancer Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Citarabina / Proteínas Proto-Oncogênicas c-mdm2 / Antineoplásicos Idioma: En Revista: Pediatr Blood Cancer Ano de publicação: 2016 Tipo de documento: Article